USFDA lifts clinical hold on Opella’s planned actual use trial to switch Cialis from prescription to OTC Read more
Zydus receives USFDA approval to conduct Phase II(b) clinical trial for Usnoflast, a novel oral NLRP3 inflammasome inhibitor in patients with ALS Read more
Alembic Pharma gets USFDA final approval for Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg Read more
Pharma sector gears up for Budget 2025-26; urges for strong regulatory framework and faster approval pathways Read more
Lupin launches Minzoya (Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ferrous Bisglycinate Tablets) in the US Read more
Pharma MSMEs ask for condition-free time frame of 2-3 years to implement revised Schedule M Read more
